Received: 15 August 2017
Accepted: 24 January 2018
First Online: 20 February 2018
: BD receives / has received consulting fees from Novo Nordisk Pharmaceuticals in regards to the SaxendaCare support program. ST has received honoraria from Shire, he chairs their Australian Clinical Advisory Committee for Binge Eating Disorder, has provided commissioned reports and has received research grant funding. He has also received royalties from Hogrefe and Huber, Mc Graw hill and Routledge for published work. He also receives an honorarium from Springer for Editor in Chief of Journal of Eating Disorders. AB has no competing interests. JR has received honoraria from Shire and has been a member of their Australian Clinical Advisory Committee for Binge Eating Disorder. She is in receipt of NHMRC funding for eating disorder research. IC has and does performed clinical trials of obesity treatment and prevention some of which have been funded by government, but others by the pharmaceutical industry; his current trials have been/are funded by the NHMRC (3), NovoNordisk, Pfizer, BMS, Australian Eggs and SFI. IC has given talks for NovoNordisk, Servier Laboratories, Ache and Pfizer in the last 3 years, serves on the scientific advisory board of the Sansom Institute for Health Research, University of SA, the board of Obesity Australia, and chair the Executive Management Committee of the national Bariatric Surgical Register, ans is president of the World Obesity Federation. PH receives/has received sessional fees and lecture fees from the Australian Medical Council, Therapeutic Guidelines publication, and New South Wales Institute of Psychiatry and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, and Blackwell Scientific Publications, Biomed Central and PlosMedicine and she has received research grants from the NHMRC and ARC. She is Deputy Chair of the National Eating Disorders Collaboration Steering Committee in Australia (2012-) and Member of the ICD-11 Working Group for Eating Disorders (2012-) and was Chair Clinical Practice Guidelines Project Working Group (Eating Disorders) of RANZCP (2012-2015). She has prepared a report under contract for Shire Pharmaceuticals in regards to Binge Eating Disorder (July 2017).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.